Boditech Med
Boditech Media
-
PRESS RELEASE
Boditech Med Reports Operating Profit of 7.15 Million USD in Q2 2024, Up 13% Year-on-Year
Sales reached 27.85 million USD (36.2 billion KRW) with an operating profit of 7.15 million USD (9.3 billion KRW) in Q2 2024
Learn More -
PRESS RELEASE
Boditech Med Signs MOU with Taiwan's BPM for Diabetic Kidney Disease Prediction Marker
MOU signed for the license of diabetic kidney disease prediction marker 'DNlite-IVD103'.
Learn More -
PRESS RELEASE
Boditech Med, Q1 2024 Sales Reach $21.6 Million (33.1 Billion Won) ... Up 12.3% YoY
Consolidated sales for Q1 2024 amounted to $21.6 million (33.1 billion won), with operating profit recorded at $4.2 million (5.9 billion won).
Learn More
Who We Are
Heading to Global Top 10 In-Vitro diagnostic Company, Boditech Med Inc
We Boditech Med have been focusing on developing key technologies of immune-diagnosis and molecular diagnosis to provide reliable In-Vitro diagnostic solutions for everyone at anywhere, and anytime.
We are constantly striving to become a global In-Vitro diagnostic company realizing the value of respect for life. And We wish to finally improve quality of life across the world.
Learn More